Correlation of glutamate levels in the anterior cingulate cortex with self-reported impulsivity in patients with borderline personality disorder and healthy controls

Archives of General Psychiatry

Volumn 67, Issue 9, 2010, Pages 946-954

  Hoerst, Mareen ^a   Weber Fahr, Wolfgang ^a   Tunc Skarka, Nuran ^a   Ruf, Matthias ^a   Bohus, Martin ^a   Schmahl, Christian ^a   Ende, Gabriele ^a  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID;

ADULT; ARTICLE; BORDERLINE STATE; BRAIN METABOLISM; CINGULATE GYRUS; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; FEMALE; HUMAN; IMAGE ANALYSIS; IMPULSIVENESS; MEASUREMENT; PROTON NUCLEAR MAGNETIC RESONANCE; SCORING SYSTEM; SELF REPORT;

ADULT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BORDERLINE PERSONALITY DISORDER; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; GERMANY; GLUTAMIC ACID; GYRUS CINGULI; HUMANS; IMPULSIVE BEHAVIOR; MAGNETIC RESONANCE SPECTROSCOPY; PERSONALITY INVENTORY; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 77956381514     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archgenpsychiatry.2010.93     Document Type: Article

References (70)

1. Coid J, Yang M, Tyrer P, Roberts A, Ullrich S. Prevalence and correlates of personality disorder in Great Britain. Br J Psychiatry. 2006;188:423-431.
2. Skodol AE, Gunderson JG, Pfohl B, Widiger TA, Livesley WJ, Siever LJ. The borderline diagnosis I: psychopathology, comorbidity, and personality structure. Biol Psychiatry. 2002;51(12):936-950. (Pubitemid 34607710)
3. Ebner-Priemer UW, Kuo J, Schlotz W, Kleindienst N, Rosenthal MZ, Detterer L, Linehan MM, Bohus M. Distress and affective dysregulation in patients with borderline personality disorder: a psychophysiological ambulatory monitoring study. J Nerv Ment Dis. 2008;196(4):314-320. (Pubitemid 351548732)
4. Lieb K, Zanarini MC, Schmahl C, Linehan MM, Bohus M. Borderline personality disorder. Lancet. 2004;364(9432):453-461.
5. Links PS, Heslegrave R, van Reekum R. Impulsivity: core aspect of borderline personality disorder. J Pers Disord. 1999;13(1):1-9. (Pubitemid 29195452)
6. Schmahl C, Bremner JD. Neuroimaging in borderline personality disorder. J Psychiatr Res. 2006;40(5):419-427.
7. Lis E, Greenfield B, Henry M, Guile JM, Dougherty G. Neuroimaging and genetics of borderline personality disorder: a review. J Psychiatry Neurosci. 2007;32(3):162-173. (Pubitemid 46903857)
8. Bush G, Luu P, Posner MI. Cognitive and emotional influences in anterior cingulate cortex. Trends Cogn Sci. 2000;4(6):215-222. (Pubitemid 30332147)
9. Tebartz van Elst L, Hesslinger B, Thiel T, Geiger E, Haegele K, Lemieux L, Lieb K, Bohus M, Hennig J, Ebert D. Frontolimbic brain abnormalities in patients with borderline personality disorder: a volumetric magnetic resonance imaging study. Biol Psychiatry. 2003;54(2):163-171. (Pubitemid 36859776)
10. Rüsch N, van Elst LT, Ludaescher P, Wilke M, Huppertz HJ, Thiel T, Schmahl C, Bohus M, Lieb K, Hesslinger B, Hennig J, Ebert D. A voxel-based morphometric MRI study in female patients with borderline personality disorder. Neuroimage. 2003;20(1):385-392. (Pubitemid 37188526)
11. Hazlett EA, New AS, Newmark R, Haznedar MM, Lo JN, Speiser LJ, Chen AD, Mitropoulou V, Minzenberg M, Siever LJ, Buchsbaum MS. Reduced anterior and posterior cingulate gray matter in borderline personality disorder. Biol Psychiatry. 2005;58(8):614-623. (Pubitemid 41565576)
12. Soloff P, Nutche J, Goradia D, Diwadkar V. Structural brain abnormalities in borderline personality disorder: a voxel-based morphometry study. Psychiatry Res. 2008;164(3):223-236.
13. Minzenberg MJ, Fan J, New AS, Tang CY, Siever LJ. Frontolimbic structural changes in borderline personality disorder. J Psychiatr Res. 2008;42(9):727-733. (Pubitemid 351636097)
14. Whittle S, Chanen AM, Fornito A, McGorry PD, Pantelis C, Yucel M. Anterior cingulate volume in adolescents with first-presentation borderline personality disorder. Psychiatry Res. 2009;172(2):155-160.
15. De La Fuente JM, Goldman S, Stanus E, Vizuete C, Morlán I, Bobes J, Mendlewicz J. Brain glucose metabolism in borderline personality disorder. J Psychiatr Res. 1997;31(5):531-541. (Pubitemid 27443114)
16. Schmahl CG, Vermetten E, Elzinga BM, Bremner JD. A positron emission tomography study of memories of childhood abuse in borderline personality disorder. Biol Psychiatry. 2004;55(7):759-765. (Pubitemid 38376189)
17. Siever LJ, Buchsbaum MS, New AS, Spiegel-Cohen J, Wei T, Hazlett EA, Sevin E, Nunn M, Mitropoulou V. d,l-Fenfluramine response in impulsive personality disorder assessed with [18F]fluorodeoxyglucose positron emission tomography. Neuropsychopharmacology. 1999;20(5):413-423. (Pubitemid 29123869)
18. Leyton M, Okazawa H, Diksic M, Paris J, Rosa P, Mzengeza S, Young SN, Blier P, Benkelfat C. Brain regional alpha-[11C]methyl-L-tryptophan trapping in impulsive subjects with borderline personality disorder. Am J Psychiatry. 2001;158(5):775-782. (Pubitemid 32429847)
19. Beblo T, Driessen M, Mertens M, Wingenfeld K, Piefke M, Rullkoetter N, Silva-Saavedra A, Mensebach C, Reddemann L, Rau H,Markowitsch HJ,Wulff H, Lange W, Berea C, Ollech I, Woermann FG. Functional MRI correlates of the recall of unresolved life events in borderline personality disorder. Psychol Med. 2006;36(6):845-856. (Pubitemid 43744778)
20. Schnell K, Herpertz SC. Effects of dialectic-behavioral-therapy on the neural correlates of affective hyperarousal in borderline personality disorder. J Psychiatr Res. 2007;41(10):837-847. (Pubitemid 46693898)
21. van Elst LT, Thiel T, Hesslinger B, Lieb K, Bohus M, Hennig J, Ebert D. Subtle prefrontal neuropathology in a pilot magnetic resonance spectroscopy study in patients with borderline personality disorder. J Neuropsychiatry Clin Neurosci. 2001;13(4):511-514.
22. Tebartz van Elst L, Ludaescher P, Thiel T, Büchert M, Hesslinger B, Bohus M, Rüsch N, Hennig J, Ebert D, Lieb K. Evidence of disturbed amygdalar energy metabolism in patients with borderline personality disorder. Neurosci Lett. 2007;417(1):36-41. (Pubitemid 46517846)
23. Hoerst M, Weber-Fahr W, Tunc-Skarka N, Ruf M, Bohus M, Schmahl C, Ende G. Metabolic alterations in the amygdala in borderline personality disorder: a proton magnetic resonance spectroscopy study. Biol Psychiatry. 2010;67(5):399-405.
24. Rüsch N, Boeker M, Buchert M, Glauche V, Bohrmann C, Ebert D, Lieb K, Hennig J, Van Elst LT. Neurochemical alterations in women with borderline personality disorder and comorbid attention-deficit hyperactivity disorder [published online March 12, 2008]. World J Biol Psychiatry. doi:10.1016/j. biopsych.2009.09.030.
25. Vogt BA, Finch DM, Olson CR. Functional heterogeneity in cingulate cortex: the anterior executive and posterior evaluative regions. Cereb Cortex. 1992;2(6):435-443.
26. Wittchen HU, Wunderlich U, Zaudig M. Strukturiertes Klinisches Interview für DSM-IV, Achse I: Psychische Störungen. Göttingen, Germany: Hogrefe; 1997.
27. Loranger AW. International Personality Disorder Examination (IPDE): DSM-IV and ICD-10 modules. Odessa, FL: Psychological Assessment Resources; 1999.
28. Barratt S. Impulsiveness subtraits: arousal and information processing. In: Spence JT, Hard CE, eds. Motivation, Emotion, and Personality. North Holland, the Netherlands: Elsevier Science; 1985:137-146.
29. Laux L, Glanzmann P, Schaffner P, Spielberger CD. Das State-Trait-Angstinventar: Theoretische Grundlagen und Handanweisung. Weinheim, Germany: Beltz; 1981.
30. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
31. Bohus M, Limberger MF, Frank U, Chapman AL, Kuhler T, Stieglitz RD. Psychometric properties of the Borderline Symptom List (BSL). Psychopathology. 2007;40(2):126-132. (Pubitemid 46220187)
32. Bernstein EM, Putnam FW. Development, reliability, and validity of a dissociation scale. J Nerv Ment Dis. 1986;174(12):727-735. (Pubitemid 17210598)
33. Freyberger HJ, Spitzer C, Stieglitz RD. Fragebogen zu Dissoziativen Symptomen (FDS). Bern, Switzerland: Verlag Hans Hubner; 1999.
34. Rösler M, Retz W, Retz-Junginger P, Thome J, Supprian T, Nissen T, Stieglitz RD, Blocher D, Hengesch G, Trott GE. Tools for the diagnosis of attention-deficit/hyperactivity disorder in adults: self-rating behaviour questionnaire and diagnostic checklist [in German]. Nervenarzt. 2004;75(9):888-895. (Pubitemid 39312514)
35. Schubert F, Gallinat J, Seifert F, Rinneberg H. Glutamate concentrations in human brain using single voxel proton magnetic resonance spectroscopy at 3 Tesla. Neuroimage. 2004;21(4):1762-1771. (Pubitemid 38446596)
36. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med. 1993;30(6):672-679.
37. Soher BJ, Young K, Bernstein A, Aygula Z, Maudsley AA. GAVA: spectral simulation for in vivo MRS applications. J Magn Reson. 2007;185(2):291-299. (Pubitemid 46635235)
38. Christiansen P, Henriksen O, Stubgaard M, Gideon P, Larsson HB. In vivo quantification of brain metabolites by 1H-MRS using water as an internal standard. Magn Reson Imaging. 1993;11(1):107-118. (Pubitemid 23050515)
39. Weber-Fahr W, Ende G, Braus DF, Bachert P, Soher BJ, Henn FA, Büchel C. A fully automated method for tissue segmentation and CSF-correction of proton MRSI metabolites corroborates abnormal hippocampal NAA in schizophrenia. Neuroimage. 2002;16(1):49-60. (Pubitemid 34852472)
40. Ethofer T, Mader I, Seeger U, Helms G, Erb M, Grodd W, Ludolph A, Klose U. Comparison of longitudinal metabolite relaxation times in different regions of the human brain at 1.5 and 3 Tesla. Magn Reson Med. 2003;50(6):1296-1301. (Pubitemid 37494031)
41. Träber F, Block W, Lamerichs R, Gieseke J, Schild HH. 1H metabolite relaxation times at 3.0 tesla: measurements of T1 and T2 values in normal brain and determination of regional differences in transverse relaxation. JMagn Reson Imaging. 2004;19(5):537-545. (Pubitemid 38619915)
42. Bertolino A, Sciota D, Brudaglio F, Altamura M, Blasi G, Bellomo A, Antonucci N, Callicott JH, Goldberg TE, Scarabino T, Weinberger DR, Nardini M. Working memory deficits and levels of N-acetylaspartate in patients with schizophreniform disorder. Am J Psychiatry. 2003;160(3):483-489. (Pubitemid 41094256)
43. Rothman DL, Behar KL, Hyder F, Shulman RG. In vivo NMR studies of the glutamate neurotransmitter flux and neuroenergetics: implications for brain function. Annu Rev Physiol. 2003;65:401-427. (Pubitemid 38249161)
44. Bozkurt A, Zilles K, Schleicher A, Kamper L, Arigita ES, Uylings HB, Kötter R. Distributions of transmitter receptors in the macaque cingulate cortex. Neuroimage. 2005;25(1):219-229. (Pubitemid 40292053)
45. Auer DP, Putz B, Kraft E, Lipinski B, Schill J, Holsboer F. Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry. 2000;47(4):305-313. (Pubitemid 30109243)
46. Pfleiderer B, Michael N, Erfurth A, Ohrmann P, Hohmann U, Wolgast M, Fiebich M, Arolt V, Heindel W. Effective electroconvulsive therapy reverses glutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients. Psychiatry Res. 2003;122(3):185-192. (Pubitemid 36412193)
47. Mirza Y, Tang J, Russell A, Banerjee SP, Bhandari R, Ivey J, Rose M, Moore GJ, Rosenberg DR. Reduced anterior cingulate cortex glutamatergic concentrations in childhood major depression. J Am Acad Child Adolesc Psychiatry. 2004;43(3):341-348. (Pubitemid 41615014)
48. Rosenberg DR, Macmaster FP, Mirza Y, Smith JM, Easter PC, Banerjee SP, Bhandari R, Boyd C, Lynch M, Rose M, Ivey J, Villafuerte RA, Moore GJ, Renshaw P. Reduced anterior cingulate glutamate in pediatric major depression: a magnetic resonance spectroscopy study. Biol Psychiatry. 2005;58(9):700-704. (Pubitemid 41547237)
49. van Elst LT, Valerius G, Buchert M, Thiel T, Rüsch N, Bubl E, Hennig J, Ebert D, Olbrich HM. Increased prefrontal and hippocampal glutamate concentration in schizophrenia: evidence from a magnetic resonance spectroscopy study. Biol Psychiatry. 2005;58(9):724-730. (Pubitemid 41547240)
50. Théberge J, Al-Semaan Y, Williamson PC, Menon RS, Neufeld RW, Rajakumar N, Schaefer B, Densmore M, Drost DJ. Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS. Am J Psychiatry. 2003;160(12):2231-2233. (Pubitemid 39619619)
51. Courvoisie H, Hooper SR, Fine C, Kwock L, Castillo M. Neurometabolic functioning and neuropsychological correlates in children with ADHD-H: preliminary findings. J Neuropsychiatry Clin Neurosci. 2004;16(1):63-69. (Pubitemid 38233365)
52. Pittenger C, Krystal JH, Coric V. Initial evidence of the beneficial effects of glutamatemodulating agents in the treatment of self-injurious behavior associated with borderline personality disorder. J Clin Psychiatry. 2005;66(11):1492-1493. (Pubitemid 41779556)
53. Philipsen A, Limberger MF, Lieb K, Feige B, Kleindienst N, Ebner-Priemer U, Barth J, Schmahl C, Bohus M. Attention-deficit hyperactivity disorder as a potentially aggravating factor in borderline personality disorder. Br J Psychiatry. 2008;192(2):118-123. (Pubitemid 351269645)
54. Kisa C, Yildirim SG, Goka E. Impulsivity and mental disorders [in Turkish]. Turk Psikiyatri Derg. 2005;16(1):46-54.
55. Lampe K, Konrad K, Kroener S, Fast K, Kunert HJ, Herpertz SC. Neuropsychological and behavioural disinhibition in adult ADHD compared to borderline personality disorder. Psychol Med. 2007;37(12):1717-1729. (Pubitemid 350100432)
56. McCloskey MS, New AS, Siever LJ, Goodman M, Koenigsberg HW, Flory JD, Coccaro EF. Evaluation of behavioral impulsivity and aggression tasks as endophenotypes for borderline personality disorder. J Psychiatr Res. 2009;43(12):1036-1048.
57. Chapman AL, Leung DW, Lynch TR. Impulsivity and emotion dysregulation in Borderline Personality Disorder. J Pers Disord. 2008;22(2):148-164. (Pubitemid 351556178)
58. Domes G, Winter B, Schnell K, Vohs K, Fast K, Herpertz SC. The influence of emotions on inhibitory functioning in borderline personality disorder. Psychol Med. 2006;36(8):1163-1172. (Pubitemid 44084019)
59. Meda SA, Stevens MC, Potenza MN, Pittman B, Gueorguieva R, Andrews MM, Thomas AD, Muska C, Hylton JL, Pearlson GD. Investigating the behavioral and self-report constructs of impulsivity domains using principal component analysis. Behav Pharmacol. 2009;20(5-6):390-399.
60. Steinberg L, Albert D, Cauffman E, Banich M, Graham S, Woolard J. Age differences in sensation seeking and impulsivity as indexed by behavior and self-report: evidence for a dual systems model. Dev Psychol. 2008;44(6):1764-1778.
61. Gallinat J, Kunz D, Lang UE, Neu P, Kassim N, Kienast T, Seifert F, Schubert F, Bajbouj M. Association between cerebral glutamate and human behaviour: the sensation seeking personality trait. Neuroimage. 2007;34(2):671-678. (Pubitemid 44827774)
62. Pattij T, Vanderschuren LJ. The neuropharmacology of impulsive behaviour. Trends Pharmacol Sci. 2008;29(4):192-199.
63. Higgins GA, Ballard TM, Huwyler J, Kemp JA, Gill R. Evaluation of the NR2B-selective NMDA receptor antagonist Ro 63-1908 on rodent behaviour: evidence for an involvement of NR2B NMDA receptors in response inhibition. Neuropharmacology. 2003;44(3):324-341. (Pubitemid 36246488)
64. Mirjana C, Baviera M, Invernizzi RW, Balducci C. The serotonin 5-HT2A receptors antagonist M100907 prevents impairment in attentional performance by NMDA receptor blockade in the rat prefrontal cortex. Neuropsychopharmacology. 2004;29(9):1637-1647. (Pubitemid 39150105)
65. Sukhotina IA, Dravolina OA, Novitskaya Y, Zvartau EE, Danysz W, Bespalov AY. Effects of mGlu1 receptor blockade on working memory, time estimation, and impulsivity in rats. Psychopharmacology (Berl). 2008;196(2):211-220.
66. Carli M, Baviera M, Invernizzi RW, Balducci C. Dissociable contribution of 5-HT1A and 5-HT2A receptors in the medial prefrontal cortex to different aspects of executive control such as impulsivity and compulsive perseveration in rats. Neuropsychopharmacology. 2006;31(4):757-767.
67. Murphy ER, Dalley JW, Robbins TW. Local glutamate receptor antagonism in the rat prefrontal cortex disrupts response inhibition in a visuospatial attentional task. Psychopharmacology (Berl). 2005;179(1):99-107.
68. Lanius RA, Williamson P, Boksman K, Densmore M, Gupta M, Neufeld RW, Gati JS, Menon RS. Brain activation during script-driven imagery induced dissociative responses in PTSD: a functional magnetic resonance imaging investigation. Biol Psychiatry. 2002;52(4):305-311. (Pubitemid 35245969)
69. Ludäscher P, Valerius G, Stiglmayr C, Mauchnik J, Lanius RA, Bohus M, Schmahl C. Pain sensitivity and neural processing during dissociative states in patients with borderline personality disorder with and without comorbid posttraumatic stress disorder: a pilot study. J Psychiatry Neurosci. 2010;35(3):177-184.
70. Krystal JHBA, Bremner JD, Southwick SM, Charney DS. Toward a cognitive neuroscience of dissociation and altered memory functions in posttraumatic stress disorder. In: Friedman MJ, Charney DS, Deutch AY, eds. Neurobiological and Clinical Consequences of Stress. Philadelphia, PA: Lippincott Williams & Wilkins; 1995:239-269.